Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Pathway Health Corp V.PHC

Pathway Health Corp is a providers of out-of-hospital pain management services in Canada. The Company owns and operates approximately 9 community-based clinics across 4 provinces. The companies patient care programs utilize an interdisciplinary approach that includes trained pain specialists, physical and occupational therapists, psychologists, nurses and other healthcare providers.

TSXV:PHC - Post Discussion

Pathway Health Corp > Corporate Update on Pharmacy Initiative
View:
Post by Betteryear2 on Dec 08, 2021 8:38am

Corporate Update on Pharmacy Initiative

TORONTODec. 8, 2021 /CNW/ - Pathway Health Corp. (TSXV: PHC) (formerly Colson Capital Corp.) ("Pathway" or the "Company") is pleased to provide an update on the progress of its pharmacy initiatives.

On December 7, 2021, Pathway Health announced its third major pharmacy agreement in 2021 with the signing of a Collaboration Agreement with Metro Ontario Pharmacies Limited, a subsidiary of Metro Inc. [TSX: MRU].  The Metro agreement pertains to the implementation of Pathway's Medical Cannabis Management System ("MCMS") in Metro Pharmacies and Food Basics Pharmacies across Ontario. 

"The Metro partnership is similar in many ways to the agreements we signed earlier this year with PharmaChoice and Sobeys," said Ken Yoon, CEO at Pathway.  "We believe these agreements reflect the pharmacy sector's recognition of a growing interest by patients and consumers in using cannabis-based products and services for a number of ailments including chronic pain, insomnia and anxiety. It's been 3 years since the legalization of recreational cannabis through retail stores in Canada and many are anticipating that the next step in the evolution of cannabis regulations will see pharmacies and pharmacists playing a central role in supporting patients interested in medical cannabis, including the distribution of cannabis-based products," said Yoon.

 
Be the first to comment on this post